| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |